| Antisense oligonucleotides: an emerging area in drug discovery and development K Dhuri, C Bechtold, E Quijano, H Pham, A Gupta, A Vikram, R Bahal Journal of clinical medicine 9 (6), 2004, 2020 | 385 | 2020 |
| Green synthesis of nanomaterials M Huston, M DeBella, M DiBella, A Gupta Nanomaterials 11 (8), 2130, 2021 | 181 | 2021 |
| Role of lipid-based and polymer-based non-viral vectors in nucleic acid delivery for next-generation gene therapy A Wahane, A Waghmode, A Kapphahn, K Dhuri, A Gupta, R Bahal Molecules 25 (12), 2866, 2020 | 172 | 2020 |
| Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium NA McNeer, K Anandalingam, RJ Fields, C Caputo, S Kopic, A Gupta, ... Nature communications 6 (1), 6952, 2015 | 155 | 2015 |
| Anti-tumor activity of miniPEG-γ-modified PNAs to inhibit microRNA-210 for cancer therapy A Gupta, E Quijano, Y Liu, R Bahal, SE Scanlon, E Song, WC Hsieh, ... Molecular Therapy-Nucleic Acids 9, 111-119, 2017 | 69 | 2017 |
| Nanotechnology for delivery of peptide nucleic acids (PNAs) A Gupta, R Bahal, M Gupta, PM Glazer, WM Saltzman Journal of Controlled Release 240, 302-311, 2016 | 69 | 2016 |
| The challenges and opportunities in the development of MicroRNA therapeutics: a multidisciplinary viewpoint MY Momin, RR Gaddam, M Kravitz, A Gupta, A Vikram Cells 10 (11), 3097, 2021 | 46 | 2021 |
| Modular evolution of DNA-binding preference of a Tbrain transcription factor provides a mechanism for modifying gene regulatory networks AM Cheatle Jarvela, L Brubaker, A Vedenko, A Gupta, BA Armitage, ... Molecular Biology and Evolution 31 (10), 2672-2688, 2014 | 38 | 2014 |
| Emerging therapeutic modalities against COVID-19 S Malik, A Gupta, X Zhong, TP Rasmussen, JE Manautou, R Bahal Pharmaceuticals 13 (8), 188, 2020 | 32 | 2020 |
| Strand invasion of DNA quadruplexes by PNA: comparison of homologous and complementary hybridization A Gupta, LL Lee, S Roy, FA Tanious, WD Wilson, DH Ly, BA Armitage ChemBioChem 14 (12), 1476-1484, 2013 | 32 | 2013 |
| In vivo correction of cystic fibrosis mediated by PNA nanoparticles AS Piotrowski-Daspit, C Barone, CY Lin, Y Deng, D Wu, TC Binns, E Xu, ... Science Advances 8 (40), eabo0522, 2022 | 28 | 2022 |
| Incorporating literature into an organic chemistry laboratory class: Translating lab activities online and encouraging the development of writing and presentation skills A Saar, M Mclaughlin, R Barlow, J Goetz, SA Adediran, A Gupta Journal of Chemical Education 97 (9), 3223-3229, 2020 | 23 | 2020 |
| Hybridization of G-quadruplex-forming peptide nucleic acids to guanine-rich DNA templates inhibits DNA polymerase η extension CT Murphy, A Gupta, BA Armitage, PL Opresko Biochemistry 53 (32), 5315-5322, 2014 | 23 | 2014 |
| Peptide Nucleic Acids Promise New Therapeutics and Gene Editing Tools R Brazil ACS Central Science 9 (1), 3-6, 2023 | 12 | 2023 |
| Teaching sustainability and environmental justice in undergraduate chemistry courses E Aoki, E Rastede, A Gupta Journal of Chemical Education 99 (1), 283-290, 2021 | 11 | 2021 |
| Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines K Dhuri, SP Pradeep, J Shi, E Anastasiadou, FJ Slack, A Gupta, X Zhong, ... Pharmaceutical Research 39 (11), 2709-2720, 2022 | 8 | 2022 |
| Therapeutic and diagnostic applications of antisense peptide nucleic acids V MacLelland, M Kravitz, A Gupta Molecular Therapy-Nucleic Acids, 2023 | 5 | 2023 |
| Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes V Kumar, A Wahane, A Gupta, JE Manautou, R Bahal Advanced Healthcare Materials 12 (12), 2202859, 2023 | 4 | 2023 |
| Genome Editing T Cathomen, M Hirsch, M Porteus New York: Springer, 2016 | 3 | 2016 |
| Nanoparticle-Mediated Correction of the Sickle Cell Mutation E Quijano, R Bahal, Y Liu, A Gupta, S Oyaghire, AS Ricciardi, HK Mandl, ... MOLECULAR THERAPY 27 (4), 278-278, 2019 | 1 | 2019 |
Peter M. GlazerYale在 yale.edu 的电子邮件经过验证
